Evidence map›Paper›PMID 37964882›Full record

ArticleFrontiers in medicine2023

Blockade of IL-18Rα-mediated signaling pathway exacerbates neutrophil infiltration in imiquimod-induced psoriasis murine model.

Hiroki Akazawa, Yuji Nozaki, Hirotaka Yamazawa, Kaori Ishimura, Chisato Ashida, Akinori Okada, Koji Kinoshita, Itaru Matsumura

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hiroki AkazawaDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Yuji NozakiDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Hirotaka YamazawaDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Kaori IshimuraDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Chisato AshidaDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Akinori OkadaDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Koji KinoshitaDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Itaru MatsumuraDepartment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Kindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is an immune-mediated inflammatory disease of the skin, which is characterized by epidermal hyperkeratosis and neutrophil infiltration. The interleukin (IL)-17/IL-23 pathway and associated cytokines play major roles in the pathogenesis and exacerbation of psoriasis. The IL-18/IL-18 receptor (R) α signaling pathway is important for Th1 cytokine production and differentiation of Th1 cells; however, its role in the pathogenesis of psoriasis remains unknown. In this study, we investigated the effect of the IL-18Rα-mediated signaling pathway in the pathogenesis of psoriasis in

Indexed as

IL-18Rαimmune-mediated inflammatory diseaseinnate immunityneutrophilpsoriasis

Identifiers

PMID37964882
PMCPMC10641785
OpenAlexW4388178231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.